BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

657 related articles for article (PubMed ID: 28728476)

  • 1. A perspective on diuretic resistance in chronic congestive heart failure.
    Shah N; Madanieh R; Alkan M; Dogar MU; Kosmas CE; Vittorio TJ
    Ther Adv Cardiovasc Dis; 2017 Oct; 11(10):271-278. PubMed ID: 28728476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Diuretic therapy in heart failure].
    Trullàs JC; Morales-Rull JL; Formiga F;
    Med Clin (Barc); 2014 Feb; 142(4):163-70. PubMed ID: 23768854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In chronic heart failure with marked fluid retention, the i.v. high doses of loop diuretic are a predictor of aggravated renal dysfunction, especially in the set of heart failure with normal or only mildly impaired left ventricular systolic function.
    De Vecchis R; Ciccarelli A; Ariano C; Cioppa C; Giasi A; Pucciarelli A; Cantatrione S
    Minerva Cardioangiol; 2011 Dec; 59(6):543-54. PubMed ID: 21330961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Diuretic therapy in acute heart failure].
    Trullàs JC; Morales-Rull JL; Formiga F
    Med Clin (Barc); 2014 Mar; 142 Suppl 1():36-41. PubMed ID: 24930082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypochloremia and Diuretic Resistance in Heart Failure: Mechanistic Insights.
    Hanberg JS; Rao V; Ter Maaten JM; Laur O; Brisco MA; Perry Wilson F; Grodin JL; Assefa M; Samuel Broughton J; Planavsky NJ; Ahmad T; Bellumkonda L; Tang WH; Parikh CR; Testani JM
    Circ Heart Fail; 2016 Aug; 9(8):. PubMed ID: 27507113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Value of aldosterone receptor blockade in diuretic therapy of patients with chronic heart failure].
    Christ M; Ludwig N; Maisch B
    Herz; 2002 Mar; 27(2):135-49. PubMed ID: 12025459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loop diuretic therapy in heart failure: the need for solid evidence on a fluid issue.
    Chiong JR; Cheung RJ
    Clin Cardiol; 2010 Jun; 33(6):345-52. PubMed ID: 20556804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diuretic response in acute heart failure-pathophysiology, evaluation, and therapy.
    ter Maaten JM; Valente MA; Damman K; Hillege HL; Navis G; Voors AA
    Nat Rev Cardiol; 2015 Mar; 12(3):184-92. PubMed ID: 25560378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacotherapy in congestive heart failure: diuretic resistance and strategies to overcome resistance in patients with congestive heart failure.
    Ravnan SL; Ravnan MC; Deedwania PC
    Congest Heart Fail; 2002; 8(2):80-5. PubMed ID: 11927781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treating Diuretic Resistance: An Overview.
    Bowman BN; Nawarskas JJ; Anderson JR
    Cardiol Rev; 2016; 24(5):256-60. PubMed ID: 27465540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid and Highly Accurate Prediction of Poor Loop Diuretic Natriuretic Response in Patients With Heart Failure.
    Testani JM; Hanberg JS; Cheng S; Rao V; Onyebeke C; Laur O; Kula A; Chen M; Wilson FP; Darlington A; Bellumkonda L; Jacoby D; Tang WH; Parikh CR
    Circ Heart Fail; 2016 Jan; 9(1):e002370. PubMed ID: 26721915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination of loop diuretics with thiazide-type diuretics in heart failure.
    Jentzer JC; DeWald TA; Hernandez AF
    J Am Coll Cardiol; 2010 Nov; 56(19):1527-34. PubMed ID: 21029871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acetazolamide to increase natriuresis in congestive heart failure at high risk for diuretic resistance.
    Verbrugge FH; Martens P; Ameloot K; Haemels V; Penders J; Dupont M; Tang WHW; Droogné W; Mullens W
    Eur J Heart Fail; 2019 Nov; 21(11):1415-1422. PubMed ID: 31074184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diuretic Resistance in Heart Failure.
    Gupta R; Testani J; Collins S
    Curr Heart Fail Rep; 2019 Apr; 16(2):57-66. PubMed ID: 30762178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loop diuretics, renal function and clinical outcome in patients with heart failure and reduced ejection fraction.
    Damman K; Kjekshus J; Wikstrand J; Cleland JG; Komajda M; Wedel H; Waagstein F; McMurray JJ
    Eur J Heart Fail; 2016 Mar; 18(3):328-36. PubMed ID: 26693947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of metolazone versus chlorothiazide in acute decompensated heart failure with diuretic resistance.
    Moranville MP; Choi S; Hogg J; Anderson AS; Rich JD
    Cardiovasc Ther; 2015 Apr; 33(2):42-9. PubMed ID: 25712736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serial direct sodium removal in patients with heart failure and diuretic resistance.
    Rao VS; Ivey-Miranda JB; Cox ZL; Moreno-Villagomez J; Ramos-Mastache D; Neville D; Balkcom N; Asher JL; Bellumkonda L; Bigvava T; Shaburishvili T; Bartunek J; Wilson FP; Finkelstein F; Maulion C; Turner JM; Testani JM
    Eur J Heart Fail; 2024 May; 26(5):1215-1230. PubMed ID: 38556717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal negative pressure treatment as a novel therapy for heart failure-induced renal dysfunction.
    Rao VS; Maulion C; Asher JL; Ivey-Miranda JB; Cox ZL; Moreno-Villagomez J; Mahoney D; Turner JM; Wilson FP; Wilcox CS; Testani JM
    Am J Physiol Regul Integr Comp Physiol; 2021 Oct; 321(4):R588-R594. PubMed ID: 34405731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel strategies: challenge loop diuretics and sodium management in heart failure--Part I.
    Pasquale PD; Sarullo FM; Paterna S
    Congest Heart Fail; 2007; 13(2):93-8. PubMed ID: 17392613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In right or biventricular chronic heart failure addition of thiazides to loop diuretics to achieve a sequential blockade of the nephron is associated with increased risk of dilutional hyponatremia: results of a case-control study.
    De Vecchis R; Ariano C; Esposito C; Giasi A; Cioppa C; Cantatrione S
    Minerva Cardioangiol; 2012 Oct; 60(5):517-29. PubMed ID: 23018431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.